Cormorant Asset Management, LP Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$688.7B
Holdings
75
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (75 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TBPHTHERAVANCE BIOPHARMA INC | 1,425,000 | $52.5B | 7.62% | |
| 2 | NVROEURNEVRO CORP | 350,000 | $32.8B | 4.76% | |
| 3 | —PROTEOSTASIS THERAPEUTICS IN | 3,804,027 | $29.7B | 4.32% | |
| 4 | GLPGGALAPAGOS NV | 300,000 | $26.1B | 3.79% | |
| 5 | ANABANAPTYSBIO INC | 895,626 | $24.9B | 3.61% | |
| 6 | ARDXARDELYX INC | 1,922,738 | $24.3B | 3.53% | |
| 7 | 2L9BLUEPRINT MEDICINES CORP | 600,000 | $24.0B | 3.48% | |
| 8 | ACRSACLARIS THERAPEUTICS INC | 800,000 | $23.9B | 3.46% | |
| 9 | —PORTOLA PHARMACEUTICALS INC | 600,000 | $23.5B | 3.41% | |
| 10 | —ALDER BIOPHARMACEUTICALS INC | 1,098,205 | $22.8B | 3.32% | |
| 11 | —QUOTIENT LTD | 2,899,000 | $20.3B | 2.94% | |
| 12 | NERVGBPMINERVA NEUROSCIENCES INC | 2,307,903 | $18.7B | 2.71% | |
| 13 | HRTXHERON THERAPEUTICS INC | 1,200,000 | $18.0B | 2.61% | |
| 14 | EGRXEAGLE PHARMACEUTICALS INC | 200,000 | $16.6B | 2.41% | |
| 15 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,940,880 | $15.4B | 2.24% | |
| 16 | —MYOKARDIA INC | 1,130,000 | $14.9B | 2.16% | |
| 17 | —JUNO THERAPEUTICS INC | 650,000 | $14.4B | 2.09% | |
| 18 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 1,686,100 | $13.9B | 2.02% | |
| 19 | WVEWAVE LIFE SCIENCES LTD | 482,079 | $13.3B | 1.92% | |
| 20 | CHRSCOHERUS BIOSCIENCES INC | 620,300 | $13.1B | 1.90% | |
| 21 | NBIXNEUROCRINE BIOSCIENCES INC | 300,000 | $13.0B | 1.89% | |
| 22 | —FORWARD PHARMA A/S | 589,175 | $12.7B | 1.84% | |
| 23 | OMEROMEROS CORP | 750,000 | $11.3B | 1.65% | |
| 24 | —ZYNERBA PHARMACEUTICALS INC | 500,000 | $10.1B | 1.46% | |
| 25 | —CHINA BIOLOGIC PRODUCTS INC | 100,000 | $10.0B | 1.45% | |
| 26 | —GEMPHIRE THERAPEUTICS INC | 952,798 | $10.0B | 1.45% | |
| 27 | JNCEEURJOUNCE THERAPEUTICS INC | 434,976 | $9.6B | 1.39% | |
| 28 | —INC RESH HLDGS INC | 200,000 | $9.2B | 1.33% | |
| 29 | PTGXPROTAGONIST THERAPEUTICS INC | 683,600 | $8.8B | 1.27% | |
| 30 | FLGTFULGENT GENETICS INC | 750,000 | $8.2B | 1.19% | |
| 31 | ARRYEURARRAY BIOPHARMA INC | 900,000 | $8.0B | 1.17% | |
| 32 | —AUDENTES THERAPEUTICS INC | 424,660 | $7.2B | 1.05% | |
| 33 | SRNESORRENTO THERAPEUTICS INC | 1,690,800 | $6.7B | 0.97% | |
| 34 | RIGLUSDRIGEL PHARMACEUTICALS INC | 2,000,000 | $6.6B | 0.96% | |
| 35 | —CONTRAFECT CORP | 3,550,000 | $6.4B | 0.93% | |
| 36 | —INVUITY INC | 756,470 | $6.0B | 0.87% | |
| 37 | DC4DEXCOM INC | 70,000 | $5.9B | 0.86% | |
| 38 | —DERMIRA INC | 170,000 | $5.8B | 0.84% | |
| 39 | —SYNERGY PHARMACEUTICALS INC | 1,200,000 | $5.6B | 0.81% | |
| 40 | —CURIS INC | 2,000,000 | $5.6B | 0.81% | |
| 41 | SCTLRECRO PHARMA INC | 590,000 | $5.2B | 0.75% | |
| 42 | RAREULTRAGENYX PHARMACEUTICAL IN | 75,000 | $5.1B | 0.74% | |
| 43 | AGENEURAGENUS INC | 1,200,000 | $4.5B | 0.66% | |
| 44 | —INTEC PHARMA LTD JERUSALEM | 809,804 | $4.1B | 0.60% | |
| 45 | —AGILE THERAPEUTICS INC | 1,250,000 | $4.0B | 0.58% | |
| 46 | CTMXCYTOMX THERAPEUTICS INC | 230,000 | $4.0B | 0.58% | |
| 47 | —PFENEX INC | 574,966 | $3.3B | 0.49% | |
| 48 | SNDXSYNDAX PHARMACEUTICALS INC | 240,403 | $3.3B | 0.48% | |
| 49 | GBYSANGAMO THERAPEUTICS INC | 600,000 | $3.1B | 0.45% | |
| 50 | COLLCOLLEGIUM PHARMACEUTICAL INC | 300,000 | $3.0B | 0.44% | |
| 51 | —ADVANCED ACCELERATOR APPLIC | 75,000 | $3.0B | 0.43% | |
| 52 | —LIPOCINE INC | 741,496 | $2.9B | 0.42% | |
| 53 | ASNDASCENDIS PHARMA A S | 100,000 | $2.8B | 0.41% | |
| 54 | —ONCOBIOLOGICS INC | 1,002,516 | $2.7B | 0.39% | |
| 55 | —EPIZYME INC | 140,000 | $2.4B | 0.35% | |
| 56 | RGNXREGENXBIO INC | 120,000 | $2.3B | 0.34% | |
| 57 | —IMMUNE DESIGN CORP | 337,000 | $2.3B | 0.33% | |
| 58 | —AVEXIS INC | 30,000 | $2.3B | 0.33% | |
| 59 | —SUNESIS PHARMACEUTICALS INC | 520,183 | $2.1B | 0.31% | |
| 60 | —TIGENIX | 129,032 | $2.0B | 0.29% | |
| 61 | —ABEONA THERAPEUTICS INC | 400,000 | $2.0B | 0.29% | |
| 62 | XLRNACCELERON PHARMA INC | 75,000 | $2.0B | 0.29% | |
| 63 | XNCRXENCOR INC | 75,000 | $1.8B | 0.26% | |
| 64 | CRVSCORVUS PHARMACEUTICALS INC | 81,000 | $1.7B | 0.24% | |
| 65 | GLYCEURGLYCOMIMETICS INC | 287,031 | $1.6B | 0.23% | |
| 66 | —HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $1.4B | 0.20% | |
| 67 | —MYOVANT SCIENCES LTD | 100,000 | $1.2B | 0.17% | |
| 68 | —APTOSE BIOSCIENCES INC | 990,579 | $1.0B | 0.15% | |
| 69 | —THRESHOLD PHARMACEUTICAL INC | 900,000 | $513.0M | 0.07% | |
| 70 | —AVEO PHARMACEUTICALS INC | 700,000 | $413.0M | 0.06% | |
| 71 | —NEOS THERAPEUTICS INC | 50,613 | $364.0M | 0.05% | |
| 72 | —ONCOBIOLOGICS INC | 416,666 | $333.0M | 0.05% | |
| 73 | —ONCOBIOLOGICS INC | 416,666 | $208.0M | 0.03% | |
| 74 | —CELLECTAR BIOSCIENCES INC | 53,649 | $122.0M | 0.02% | |
| 75 | —CELLECTAR BIOSCIENCES INC | 52,999 | $20.0M | 0.00% |